EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at The Wall Street Analyst Forum 22nd Annual Analyst Conference to be held on Tuesday, March 1, at The University Club (1 West 54th Street) in NYC.
